Related Experiment Videos
Matrix metalloproteinases: pro- and anti-angiogenic activities
1Department of Medicine, Washington University School of Medicine at Barnes-Jewish Hospital, St. Louis, Missouri 63110, USA.
The Journal of Investigative Dermatology. Symposium Proceedings
|January 9, 2001
Summary
Matrix metalloproteinases (MMPs) degrade extracellular matrix and have roles in normal and pathologic processes like tumor growth. MMP inhibitors are studied for cancer therapy, but their broad-spectrum use requires careful consideration of MMPs' diverse functions.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Matrix metalloproteinases (MMPs) are enzymes with diverse functions beyond extracellular matrix degradation.
- MMPs regulate processes like development, wound healing, and are implicated in tumor growth and angiogenesis.
- MMP activity is tightly controlled by gene expression, proenzyme activation, and tissue inhibitors of metalloproteinases (TIMPs).
Purpose of the Study:
- To review the role of MMPs in tumor invasion and angiogenesis.
- To discuss the design and therapeutic application of MMP inhibitors in cancer.
- To evaluate the appropriateness of nonselective MMP inhibition given MMPs' multifaceted roles.
Main Methods:
- Literature review focusing on MMPs' contribution to tumor invasion and angiogenesis.
- Analysis of MMP regulation and function.
- Discussion of synthetic MMP inhibitors, including hydroxymates, and their clinical relevance.
Main Results:
- MMPs are crucial for tumor invasion and the formation of new blood vessels (angiogenesis).
- Synthetic MMP inhibitors show potential for therapeutic intervention in cancer.
- The non-matrix degrading functions of MMPs complicate the strategy of nonselective inhibition.
Conclusions:
- MMPs play a significant role in tumor progression, necessitating targeted therapeutic strategies.
- MMP inhibitors represent a promising avenue for cancer treatment, but specificity is key.
- Further research into MMP functions is essential for optimizing therapeutic approaches in oncology.